To Örebro University

oru.seÖrebro University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Emergence of Multidrug- and Pandrug- Resistant Pseudomonas aeruginosa from Five Hospitals in Qatar
Örebro University, School of Science and Technology. Microbiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar. (The Life Science Centre-Biology)ORCID iD: 0000-0002-6186-7770
Division of General Medicine, Wayne State University, Detroit MI, USA.
Departments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Departments of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Show others and affiliations
2019 (English)In: Infection Prevention in Practice, E-ISSN 2590-0889, Vol. 1, no 3-4, article id 100027Article in journal (Refereed) Published
Abstract [en]

Background: A global rise in multidrug-resistant (MDR) nosocomial infections has led to a significant increase in morbidity and mortality. MDR Gram-negative bacteria (GNB) are recognised for rapidly developing drug resistance. Despite Pseudomonas aeruginosa being the second most common GNB isolated from healthcare associated infections, the magnitude of MDR P. aeruginosa (MDR-PA) has not been evaluated in Qatar.

Aim: To assess the prevalence and antimicrobial susceptibility patterns of MDR-PA from 5major hospitals in Qatar.

Methods: A total of 2533P. aeruginosaclinical isolates were collected over a one-year period. MDR-PA was defined as resistance to at least one agent of3 antibiotic classes. Clinical and demographic data were collected prospectively.

Findings: The overall prevalence of MDR-PA isolates was 8.1% (205/2533); the majority of isolates were from patients exposed to antibiotics during 90 days prior to isolation (85.4%,177/205), and the infections were mainly hospital-acquired (95.1%, 195/205) with only 4.9% from the community. The majority of MDR-PA isolates were resistant to cefepime (96.6%, 198/205), ciprofloxacin, piperacillin/tazobactam (91%, 186/205), and meropenem (90%, 184/205). Patient comorbidities with MDR-PA were diabetes mellitus (47.3%, n¼97), malignancy (17.1%, n¼35), end-stage renal disease (13.7%, n¼28) and heart failure (10.7%, n¼22).

Conclusion: There was a significant prevalence of MDR-PA in Qatar, primarily from healthcare facilities and associated with prior antibiotic treatment. There was an alarming level of antimicrobial resistance to carbapenems. Our results are part of a national surveillance of MDR to establish effective containment plans.

Place, publisher, year, edition, pages
Elsevier, 2019. Vol. 1, no 3-4, article id 100027
Keywords [en]
Gram-negative bacteria, Antibiotic resistance, Antimicrobial susceptibility, Carbapenem, Cephalosporin, Hospital-acquired infections
National Category
Infectious Medicine Immunology in the medical area
Identifiers
URN: urn:nbn:se:oru:diva-87548DOI: 10.1016/j.infpip.2019.100027ISI: 001024904500001Scopus ID: 2-s2.0-85107459189OAI: oai:DiVA.org:oru-87548DiVA, id: diva2:1503363
Funder
Swedish Research Council Formas, 219-2014-837
Note

Funding Agency:

Hamad Medical Corporation RGC-01-51-033

Available from: 2020-11-24 Created: 2020-11-24 Last updated: 2023-12-08Bibliographically approved
In thesis
1. Molecular Epidemiology and Mechanisms of Antibiotic Resistance in Clinical Isolates of Pseudomonas aeruginosa from Qatar
Open this publication in new window or tab >>Molecular Epidemiology and Mechanisms of Antibiotic Resistance in Clinical Isolates of Pseudomonas aeruginosa from Qatar
2020 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Inappropriate and excessive use of antibiotics promotes antimicrobial resistance (AMR), particularly in Gram-negative bacteria (GNB). There is a noticeable increase in nosocomial infections caused by multidrug-resistant (MDR) Pseudomonas aeruginosa, which is associated with significant morbidity, mortality, and an increase in cost management. Although this is a global problem, there is a lack of sufficient data on regional differences that can contribute towards effective AMR management. This thesis presents a study of MDR-P. aeruginosa at five different hospitals in Qatar conducted prospectively between October 2014 - September 2017. The aim was to study the epidemiology, microbiological and clinical characteristics of MDR-P. aeruginosa infections as well as investigate the activity of new antibiotic combinations against these bacteria. The prevalence of MDR-P. aeruginosa isolates in the first year was 8.1% (205/2533), isolated from different clinical specimens, but the majority were from respiratory infections (44.9%, n=92). Most cases were exposed to antibiotics during the 90 days prior to isolation (85.4%, n=177), and the resistance to cefepime, ciprofloxacin, piperacillin/tazobactam, meropenem was >90%. To compare pre- and post-Antimicrobial Stewardship Program, there was a significant reduction in antibiotic consumption by 30.4% of total inpatient antibiotic prescriptions (p=0.008) and the prevalence of MDR-P. aeruginosa significantly declined from 9% to 5.4% (p=0.019). The in vitro investigation of ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (C/T) against MDR-P. aeruginosa isolates, showed promising results with susceptibility of 68.8% (n=141/205) and 62.9% (n=129/205), respectively, which was higher than other antipseudomonal agents except colistin. Seventy-five isolates that were sequenced belonged to 29 different sequence types, with ST235 being predominant at 21.3% (16/75). Among the 42 isolates that were resistant to CZA and/or C/T, the most prevalent genes were blaOXA-488 and blaVEB-9 detected in 45.2% (19/42) of isolates. Spearman’s analysis showed that resistance to CZA and C/T were positively correlated with the presence of blaOXA-10, blaPDC-2a, blaVIM-2, and blaVEB-9 , respectively. The study highlights potential key mechanisms that could explain the resistance of MDR-P. aeruginosa to the new antibiotic combinations.

Place, publisher, year, edition, pages
Örebro: Örebro University, 2020. p. 92
Series
Örebro Studies in Life Science, ISSN 1653-3100 ; 17
Keywords
Antibiotics, C/T, CZA, MDR, Pseudomonas aeruginosa, ST235, VEB, VIM
National Category
Other Biological Topics
Identifiers
urn:nbn:se:oru:diva-85159 (URN)978-91-7529-353-0 (ISBN)
Public defence
2020-12-16, Örebro universitet, Långhuset, Hörsal L2, Fakultetsgatan 1, Örebro, 13:15 (English)
Opponent
Supervisors
Note

I den fysiska versionen av avhandlingen är den angivna tidpunkten för avhandlingen 21 oktober, 2020, 13:00 med plats Hörsal F, Forumhuset, Örebro universitet. Disputationen blev dock inställd och fick nytt datum och plats (dessa anges ovan).

Available from: 2020-08-26 Created: 2020-08-26 Last updated: 2023-01-26Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Sid Ahmed, MazenSöderquist, BoJass, Jana

Search in DiVA

By author/editor
Sid Ahmed, MazenSöderquist, BoJass, Jana
By organisation
School of Science and TechnologySchool of Medical Sciences
In the same journal
Infection Prevention in Practice
Infectious MedicineImmunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 248 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf